Literature DB >> 10070879

Modification of non-conservative double-strand break (DSB) rejoining activity after the induction of cisplatin resistance in human tumour cells.

R A Britten1, S Kuny, S Perdue.   

Abstract

The induction of collateral radioresistance after the development of cisplatin resistance is a well-documented phenomenon; however, the exact processes that are responsible for the cisplatin-induced radioresistance remain to be elucidated. There was no obvious difference in the level of radiation-induced DNA double strand breaks (DSBs), in DSB rejoining rates, or the level of the catalytic subunit of the DNA-dependent protein kinase (DNA-PKcs) in the cisplatin- and radiation-sensitive 2780/WT and cisplatin-resistant 2780/CP cell lines. However, there was a significantly (P < 0.01) lower level of DSB misrejoining activity within nuclear protein extracts derived from the cisplatin- and radiation-sensitive 2780/WT and OAW42/WT tumour cell lines than in similar extracts from their cisplatin- (and radiation-) resistant 2780/CP and OAW42/CP counterparts. All of the DSB misrejoining events involved deletions of between 134 and 444 bp that arose through illegitimate recombination at short repetitive sequences, such as those that arise through non-homologous repair (NHR). These data further support the notion that the radiosensitivity of DSB repair proficient human tumour cell lines may be partly determined by the predisposition of these cell lines to activate non-conservative DSB rejoining pathways. Furthermore, our data suggest that the induction of acquired cisplatin resistance is associated with a two- to threefold decrease in the activity of a non-conservative DSB rejoining mechanism that appears to be a manifestation of NHR.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10070879      PMCID: PMC2362674          DOI: 10.1038/sj.bjc.6690135

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  32 in total

Review 1.  Clonal variation of DNA repair in a human glioma cell line.

Authors:  S Powell; T J McMillan
Journal:  Radiother Oncol       Date:  1991-08       Impact factor: 6.280

2.  Radiation response of human lung cancer cells with inherent and acquired resistance to cisplatin.

Authors:  P R Twentyman; K A Wright; T Rhodes
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-02       Impact factor: 7.038

3.  DNA-break repair, radioresistance of DNA synthesis, and camptothecin sensitivity in the radiation-sensitive irs mutants: comparisons to ataxia-telangiectasia cells.

Authors:  J Thacker; A N Ganesh
Journal:  Mutat Res       Date:  1990-03       Impact factor: 2.433

4.  Association among DNA/chromosome break rejoining rates, chromatin structure alterations, and radiation sensitivity in human tumor cell lines.

Authors:  J L Schwartz; A T Vaughan
Journal:  Cancer Res       Date:  1989-09-15       Impact factor: 12.701

5.  Cell cycle-dependent repair of double-strand DNA breaks in a gamma-ray-sensitive Chinese hamster cell.

Authors:  A Giaccia; R Weinstein; J Hu; T D Stamato
Journal:  Somat Cell Mol Genet       Date:  1985-09

6.  Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay.

Authors:  T Hida; R Ueda; T Takahashi; H Watanabe; T Kato; M Suyama; T Sugiura; Y Ariyoshi; T Takahashi
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

7.  Differential level of DSB repair fidelity effected by nuclear protein extracts derived from radiosensitive and radioresistant human tumour cells.

Authors:  R A Britten; D Liu; S Kuny; M J Allalunis-Turner
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  The use of recombinant DNA plasmids for the determination of DNA-repair and recombination in cultured mammalian cells.

Authors:  R Cox; W K Masson; P G Debenham; M B Webb
Journal:  Br J Cancer Suppl       Date:  1984

9.  Biochemical studies of homologous and nonhomologous recombination in human cells.

Authors:  R Fishel; M K Derbyshire; S P Moore; C S Young
Journal:  Biochimie       Date:  1991 Feb-Mar       Impact factor: 4.079

10.  A DNA repair defect in a radiation-sensitive clone of a human bladder carcinoma cell line.

Authors:  S N Powell; S J Whitaker; S M Edwards; T J McMillan
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

View more
  4 in total

1.  Vanillins--a novel family of DNA-PK inhibitors.

Authors:  Stephen Durant; Peter Karran
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

Review 2.  Nanopreparations to overcome multidrug resistance in cancer.

Authors:  Niravkumar R Patel; Bhushan S Pattni; Abraham H Abouzeid; Vladimir P Torchilin
Journal:  Adv Drug Deliv Rev       Date:  2013-08-23       Impact factor: 15.470

3.  Inhibition of ERβ induces resistance to cisplatin by enhancing Rad51-mediated DNA repair in human medulloblastoma cell lines.

Authors:  Anna Wilk; Agnieszka Waligorska; Piotr Waligorski; Augusto Ochoa; Krzysztof Reiss
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

4.  Identification Of Natural Compound Derivative For Inhibition Of XLF And Overcoming Chemoresistance In Colorectal Cancer Cells.

Authors:  Zhuo Liu; Miao Yu; Bingyuan Fei; Jing Sun; Dongxin Wang
Journal:  Drug Des Devel Ther       Date:  2019-11-06       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.